Kwality Pharmaceuticals Closes Trading Window for Insider Trading

Kwality Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This measure, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, will be in effect from October 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ended September 30, 2026. The specific date for the board meeting to consider these results will be communicated separately. This action is a standard procedure to prevent potential insider trading during sensitive financial reporting periods.